Pact Pharma Stock

pactpharma.comBioTechFounded: 2017Funding to Date: $266.25MM

PACT Pharma clinical stage biotechnology company developing personalized adoptive T cell therapies for the eradication of solid tumors.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Pact Pharma, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Timothy Moore
Chief Technical Officer & President
Alex Franzusoff Ph.D
Chief Scientific Officer
David Baltimore Ph.D
Scientific Co-Founder & Chairman of Scientific Advisory Board
Juan Jaen Ph.D
Co-Founder & Board Member
Terry Rosen Ph.D
Co-Founder & Board Member
Antoni Ribas Ph.D
Scientific Co-Founder & Board Member
James Heath Ph.D
Scientific Co-Founder & Board Member
Blake Byers Ph.D
Interim President & Board Member

Board Members

Antoni Ribas Ph.D
Blake Byers Ph.D
David Baltimore Ph.D
James Heath Ph.D
Juan Jaen Ph.D
KT Moortgat Ph.D
AbbVie Ventures
Terry Rosen Ph.D

Other companies like Pact Pharma in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM

News

PACT Pharma, a SouthSan Francisco, Calif.-based advancing personalized NeoTCR-T cell therapies to eradicate solid tumors, closed a $75m Series C financing
South San Francisco-based PACT Pharma, a provider of personalized cell therapy for solid tumors, has appointed Tim Moore as president and chief technical officer. Previously, Moore worked at Kite where he was executive vice president of technical operations. PACT Pharma's backers included GV, Canaan, Casdin Capital, Droia, Foresite Capital, Invus, Pontifax, Wu Capital, AbbVie Ventures and Taiho Ventures.